CTMG’s Chief Quality Systems Engineer / Director of Quality Systems receives Honors

Michelle Nanney, BSE, MS, MBA, who serves as CTMG, Inc.’s Chief Quality Systems Engineer / Director of Quality Systems, has recently received honors from two nationally recognized engineering societies. Ms. Nanney has been elected a Senior Member of IEEE (Institute of Electrical and Electronics Engineers). IEEE has over 421,000 members in over 160 countries. The […]

Independent Auditor Gives CTMG High Marks

CTMG recently had an independent audit performed for one of their clinical trials. The auditor stated that he found CTMG’s processes to be sound with no deficiencies. He remarked on CTMG’s state-of-the-art temperature monitoring system and praised the Quality Systems department for their EDC verification process. He also stated that he had never completed his […]

Professional Patients: A Problem for Clinical Trials

A recent Forbes article details the unseen world of individuals who pose as appropriate participants for multiple clinical studies to reap the rewards that stipends provide. Networking via social media has refined the process to include a ‘scout’ participant who relays study inclusion/exclusion criteria to the group to ensure that all who follow know just […]

Process control for key enrollment events – how any site can use a partner SSRO to ensure study completion timelines are met as intended

Subject enrollment into a clinical trial is one of the most important aspects that ensure the study will be completed within the timeframe intended. Although it seems like a straightforward and simple process, there are multiple inputs and process steps involved. Finding the right patients: For a busy clinical site – the kind that a […]

Busy Clinical Sites Need Support to Carry out Protocol Procedures as Intended – the SSRO Solution

Neither physicians nor other investigative site personnel are trained in process development and verification – skills that are evermore necessary as study protocols become more complex and seek to identify treatment effects that are more subtle or difficult to distinguish within already medicated patient populations. Because of this, disruptions that occur to patient progress in […]